FDA grants Priority Review for Lynparza in metastatic breast cancer October 18, 2017 CenterWatch Staff
Eli Lilly’s Verzenio grabs Priority Review for advanced breast cancer October 13, 2017 CenterWatch Staff
H3 granted orphan designation for hepatocellular carcinoma treatment H3B-6527 October 11, 2017 CenterWatch Staff